The FDA is considering approving a groundbreaking new treatment that uses gene editing to potentially cure sickle cell disease, offering hope for those suffering from the painful and deadly disease.
The FDA is considering approving a groundbreaking new treatment that uses gene editing to potentially cure sickle cell disease, offering hope for those suffering from the painful and deadly disease.